Ahentaz 4.5 Injection
Marketer
Ahen Pharmaceuticals
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Ahentaz 4.5 Injection
Ahentaz 4.5 Injection combines two antibiotics to combat diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, self-injection is strictly prohibited. Dosage and frequency are determined by your physician, based on illness severity, and adherence to their prescribed regimen is crucial. Common side effects may include nausea, vomiting, diarrhea, and skin rash, along with injection site reactions such as pain, swelling, or redness. Persistent or worsening side effects warrant immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver conditions; your doctor may adjust the dosage or prescribe an alternative. Generally considered safe during pregnancy and breastfeeding under medical guidance.
Primary Ingredients of Ahentaz 4.5 Injection
No information provided. A rephrased version cannot be created.
Uses of Ahentaz 4.5 Injection
Infections caused by bacteria
Major Benefits of Ahentaz 4.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ahentaz 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Ahentaz 4.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ahentaz 4.5 Injection works:
Ahentaz 4.5 Injection unites Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counteracts bacterial resistance, thereby bolstering Piperacillin's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ahentaz 4.5 Injection may be consumed concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ahentaz 4.5 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, research in human pregnancies is restricted.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Ahentaz 4.5 poses no known breastfeeding risk. Research in humans indicates negligible transfer to breast milk, presenting minimal hazard to infants.
DrivingCONSULT YOUR DOCTOR
The effect of Ahentaz 4.5 Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Administering Ahentaz 4.5 Injection to individuals with impaired renal function requires careful consideration. Dosage modification for Ahentaz 4.5 Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Ahentaz 4.5 Injection appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Ahentaz 4.5 Injection :
Omit a scheduled Ahentaz 4.5 Injection? Seek your physician's advice.
Facts to Know About Ahentaz 4.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |



